Registered entities
Domain Therapeutics
Reg. No. 439510512France
Innovation
24 patent families (11 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 2,566 times.
| Year | Filings |
|---|---|
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 10 |
| 2025 | 10 |
| 2026 | 2 |
Social engagement
Social engagement: 10.4K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
28 investors on record; lead investors include Seventure Partners, Panacea Venture, CTI Life Sciences Fund, 3B Future Health Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 12 | 43% |
| Private equity | 5 | 18% |
| Bank & private debt | 1 | 4% |
| Other / undisclosed | 10 | 36% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
29 Apr 2024 · Coordinateur d’études cliniques (H/F) · Illkirch
10 Apr 2024 · Comptable en apprentissage (H/F) · Illkirch
Based on job postings tracked across public sources.
Recent activity
18 Dec 2025
Milestone
cert
17 Dec 2025
Event
J.P. Morgan Healthcare Conference
13 Nov 2025
Leadership hire
Chief Medical Officer